Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND
posted on 2020-11-13, 11:44authored byPavle Repovic, Derrick Robertson, Kiren Kresa-Reahl, Stanley L. Cohan, Ray Su, Robin Avila, Irene Koulinska, Jason P. Mendoza
Article full
text
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).